Deep search
Profile Picture
  • All
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Past 7 days
    • Any time
    • Past hour
    • Past 24 hours
    • Past 30 days
  • Most recent
    • Best match

News

The Lancet3d
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
Copyright: © 2015 Elsevier Ltd. Published by Elsevier Ltd.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

Musk leaving Trump admin
US targets Chinese students
‘The Golden Child' actor dies
DOJ probes California
Trump nominates Emil Bove
Gray whale deaths in CA
Rock slide hits Swiss village
HHS cancels contract
Sells Rhode in $1B deal
16 states sue Trump admin
Trump commutes sentence
Mysterious object spotted
Kevin Costner sued
Killer heat ahead?
Wins first AJGA tournament
Thunder reach NBA Finals
NYC HS student detained
Man charged in CT shooting
DOGE can access data
Pardons reality TV stars
Alex Foster dies
Judge grants ICE bail
Federal court blocks tariffs
Sumo has a new champion
Migrant boat capsizes
Recalls over 1M vehicles
Charged w/ rape, trafficking
Creators tease return
OH lawyer pleads not guilty
Lifts most Syria sanctions
To undergo elbow surgery
Sentenced for abusing kids
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy